Wedbush reaffirmed their outperform rating on shares of Disc Medicine (NASDAQ:IRON – Free Report) in a report issued on Monday morning, RTT News reports. Wedbush currently has a $43.00 price objective on the stock, down from their prior price objective of $84.00. Wedbush also issued estimates for Disc Medicine’s Q4 2024 earnings at ($1.19) EPS, […]
Raymond James restated their outperform rating on shares of Disc Medicine (NASDAQ:IRON – Free Report) in a research report sent to investors on Monday, MarketBeat Ratings reports. Raymond James currently has a $40.00 target price on the stock, down from their prior target price of $75.00. IRON has been the subject of several other reports. […]
Disc Medicine (NASDAQ:IRON – Get Free Report) had its price objective decreased by research analysts at Stifel Nicolaus from $104.00 to $71.00 in a note issued to investors on Tuesday, Benzinga reports. The firm presently has a “buy” rating on the stock. Stifel Nicolaus’ price objective suggests a potential upside of 107.54% from the stock’s […]
BMO Capital Markets Cuts Disc Medicine (NASDAQ:IRON) Price Target to $50 00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Disc Medicine (NASDAQ:IRON) Price Target Cut to $50 00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.